Maturitas
Volume 57, Issue 4 , Pages 338-346 , 20 August 2007

Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-α mRNA in Ishikawa cells: Implication for tibolone's effects on the endometrium

  • Sebastian Mirkin
    • ,
  • David F. Archer

      Affiliations

    • Corresponding Author InformationCorresponding author at: CONRAD Clinical Research Center, Jones Institute for Reproductive Medicine, 601 Colley Avenue, Norfolk, VA 23507, United States. Tel.: +1 757 446 7444; fax: +1 757 446 8998.

Received 15 June 2006 ,Revised 2 March 2007 ,Accepted 14 March 2007.

References 

  1. Al-Azzawi F, Habiba M. Regular bleeding on hormone replacement therapy: a myth?. Br J Obstet Gynaecol. 1994;101:661–662
  2. Limouzin-Lamothe MA. What women want from hormone replacement therapy: results of an international survey. Eur J Obstet Gynecol Reprod Biol. 1996;64(Suppl.):S21–S24
  3. Newton KM, LaCroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. Women's beliefs and decisions about hormone replacement therapy. J Womens Health. 1997;6:459–465
  4. Archer DF, Hendrix S, Gallagher C, et al. Endometrial effects of tibolone. J Clin Endocrinol Metab 2006;27 December [Epub ahead of print].
  5. Steckelbroeck S, Jin Y, Oyesanmi B, Kloosterboer HJ, Penning TM. Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid. Mol Pharmacol. 2004;66(6):1702–1711
  6. de Gooyer ME, Deckers GH, Schoonen WG, Verheul HA, Kloosterboer HJ. Receptor profiling and endocrine interactions of tibolone. Steroids. 2003;68:21–30
  7. Kloosterboer HJ. Tissue-selectivity: the mechanism of action of tibolone. Maturitas. 2004;48(Suppl. 1):S30–S40
  8. Markiewicz L, Gurpide E. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium. J Steroid Biochem. 1990;35:535–541
  9. Schatz F, Kuczynski E, Kloosterboer HJ, et al. Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: evidence of progestogenic effects. Steroids. 2005;70:840–845
  10. Mirkin S, Mahony MC, Archer DF. Effect of tibolone and its metabolites on VEGF 121 and 165 isoforms and TSP-1 mRNA in Ishikawa cells. Menopause. 2004;11:82–88
  11. Langer RD, et al. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study. Am J Obstet Gynecol. 2006;195:1320–1327
  12. Rees M, Hague S, Oehler MK, Bicknell R. Regulation of endometrial angiogenesis. Climacteric. 1999;2:52–58
  13. Krikun G, Sakkas D, Schatz F, et al. Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception. Am J Pathol. 2004;164:2101–2107
  14. Mathur R, Smith SK. Endometrial angiogenesis: physiology and clinical implications. J Fam Plann Reprod Health Care. 2002;28:173–174
  15. Blumenthal RD, Taylor AP, Goldman L, Brown G, Goldenberg DM. Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium. Fertil Steril. 2002;78:1294–1300
  16. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem. 1998;273:18514–18521
  17. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol. 1998;8:529–532
  18. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ Res. 2000;86:24–29
  19. Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999;286:2511–2514
  20. Zhang J, Salamonsen LA. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. J Clin Endocrinol Metab. 2002;87:2346–2351
  21. Hunt JS, Chen HL, Hu XL, Tabibzadeh S. Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium. Biol Reprod. 1992;47:141–147
  22. Archer DF, Navarro FJ, Leslie S, Mirkin S. Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells. Fertil Steril. 2004;81:165–170
  23. von Wolff M, Classen-Linke I, Heid D, et al. Tumor necrosis factor-alpha (TNF-alpha) in human endometrium and uterine secretion: an evaluation by immunohistochemistry, ELISA and semiquantitative RT-PCR. Mol Hum Reprod. 1999;5:146–152
  24. Juneau P. Simultaneous non-parametric inference in a one-way layout using the SAS® system. In: SAS Conference Proceedings. 2004;
  25. Nishida M, Kasahara K, Oki A, Satoh T, Arai Y, Kubo T. Establishment of eighteen clones of Ishikawa cells. Hum Cell. 1996;9:109–116
  26. Lessey BA, Ilesanmi AO, Castelbaum AJ, et al. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin. J Steroid Biochem Mol Biol. 1996;59:31–39
  27. Kayisli UA, Aksu CA, Berkkanoglu M, Arici A. Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab. 2002;87:5539–5544
  28. Barsalou A, Dayan G, Anghel SI, Alaoui-Jamali M, Van de Velde P, Mader S. Growth-stimulatory and transcriptional activation properties of raloxifene in human endometrial Ishikawa cells. Mol Cell Endocrinol. 2002;190:65–73
  29. Hickey M, Pillai G, Higham JM, et al. Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding. Hum Reprod. 2003;18:1100–1106
  30. Rogers PA, Abberton KM. Endometrial arteriogenesis: vascular smooth muscle cell proliferation and differentiation during the menstrual cycle and changes associated with endometrial bleeding disorders. Microsc Res Tech. 2003;60:412–419
  31. Hewett P, Nijjar S, Shams M, Morgan S, Gupta J, Ahmed A. Down-regulation of angiopoietin-1 expression in menorrhagia. Am J Pathol. 2002;160:773–780
  32. Blok LJ, De Ruiter PE, Kuhne EC, et al. Progestogenic effects of tibolone on human endometrial cancer cells. J Clin Endocrinol Metab. 2003;88:2327–2334
  33. Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol Hum Reprod. 1996;2:77–92
  34. von Wolff M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod. 2000;6:627–634
  35. Salamonsen LA, Woolley DE. Matrix metalloproteinases in normal menstruation. Hum Reprod. 1996;11(Suppl. 2):124–133
  36. Vincent AJ, Salamonsen LA. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod. 2000;15:135–143
  37. Roby KF, Laham N, Hunt JS. Cellular localization and steroid hormone regulation of mRNA encoding tumour necrosis factor receptor I in mouse uterus. J Reprod Fertil. 1996;106:285–290
  38. Laird SM, Tuckerman EM, Saravelos H, Li TC. The production of tumour necrosis factor alpha (TNF-alpha) by human endometrial cells in culture. Hum Reprod. 1996;11:1318–1323
  39. Brooks-Asplund EM, Tupper CE, Daun JM, Kenney WL, Cannon JG. Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women. Cytokine. 2002;19:193–200
  40. Popovici RM, Kao LC, Giudice LC. Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology. Endocrinology. 2000;141:3510–3513
  41. Bernard-Poenaru O, Roux C, Blanque R, Gardner C, de Vemejoul MC, Cohen-Solal ME. Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study. Osteoporos Int. 2001;12:769–776
  42. Schatz F, Kuczynski E, Kloosterbooer L, et al. Tibolone exerts progestational inhibition of matrix metalloproteinase expression in human endometrial stromal cells. Steroids. 2006;71:768–775

PII: S0378-5122(07)00120-X

doi: 10.1016/j.maturitas.2007.03.002

Maturitas
Volume 57, Issue 4 , Pages 338-346 , 20 August 2007

Article Tools

* Image Usage & Resolution